Literature DB >> 1422213

A modified vector for the controlled high-level overproduction of staphylococcal protein A fusion proteins in the periplasm of Escherichia coli.

H Engel1, H Mottl, W Keck.   

Abstract

A vector encoding the Staphylococcal protein A was modified by cloning the spa gene, including its signal peptide-encoding sequence, downstream of the translation initiation sites of the phage lambda cro gene and under the control of the temperature-inducible phage lambda pR promoter. The expression from this construct was studied using the Escherichia coli phoA gene as a reporter gene after fusion to the spa gene. Determination of alkaline phosphatase activity, 1 h after temperature induction of expression at 42 degrees C, revealed an 800-fold increase over host strain background level. The presence of the alternating selectable markers on the described vector, pHEMa153, which are essential for efficient oligonucleotide-directed construction of mutations by the gapped duplex DNA method, allows the construction of recombinant and mutated forms of Staphylococcal protein A fusion proteins and efficient expression of spa gene fusions without changing the vector system.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1422213

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  3 in total

1.  Murein-metabolizing enzymes from Escherichia coli: existence of a second lytic transglycosylase.

Authors:  H Engel; A J Smink; L van Wijngaarden; W Keck
Journal:  J Bacteriol       Date:  1992-10       Impact factor: 3.490

2.  Enzymatic preparation of 1,6-anhydro-muropeptides by immobilized murein hydrolases from Escherichia coli fused to staphylococcal protein A.

Authors:  H Engel; A van Leeuwen; A Dijkstra; W Keck
Journal:  Appl Microbiol Biotechnol       Date:  1992-09       Impact factor: 4.813

Review 3.  Protein fusion tags for efficient expression and purification of recombinant proteins in the periplasmic space of E. coli.

Authors:  Ajamaluddin Malik
Journal:  3 Biotech       Date:  2016-02-04       Impact factor: 2.406

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.